DOCSLIB.ORG

Regulation of GSK3 Cellular Location by FRAT Modulates Mtorc1-Dependent Cell Growth and Sensitivity to Rapamycin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Regulation of GSK3 Cellular Location by FRAT Modulates Mtorc1-Dependent Cell Growth and Sensitivity to Rapamycin Regulation of GSK3 cellular location by FRAT modulates mTORC1-dependent cell growth and sensitivity to rapamycin Long Hea,b,c,1, Dennis Liang Feia, Michal J. Nagieca,b, Anders P. Mutveia,b, Andreas Lamprakisa,b, Bo Yeon Kimc, and John Blenisa,b,1 aMeyer Cancer Center, Weill Cornell Medical College, New York, NY 10021; bDepartment of Pharmacology, Weill Cornell Medical College, New York, NY 10021; and cWorld Class Institute, Korea Research Institute of Bioscience and Biotechnology, 363-883 Ochang, Korea Edited by Michael N. Hall, University of Basel, Basel, Switzerland, and approved August 5, 2019 (received for review February 10, 2019) The mTORC1 pathway regulates cell growth and proliferation by stimulation by multiple growth factors (3). This suppression is properly coupling critical processes such as gene expression, protein predominantly achieved via phosphorylation at Ser21 or Ser9, translation, and metabolism to the availability of growth factors and respectively, on GSK3α/β by multiple kinases (5). For example, hormones, nutrients, cellular energetics, oxygen status, and cell inhibitory phosphorylation of GSK3 was shown to be regulated by stress. Although multiple cytoplasmic substrates of mTORC1 have mTORC1/S6K1 and contribute to mTORC1-mediated suppression been identified, how mTORC1 signals within the nucleus remains of GSK3 activity (6). Interestingly, high levels of inhibitory GSK3 incompletely understood. Here, we report a mechanism by which phosphorylation or GSK3 inhibitors were reported to confer mTORC1 modulates the phosphorylation of multiple nuclear events. rapamycin resistance in certain cell types (7, 8). GSK3 also phos- We observed a significant nuclear enrichment of GSK3 when mTORC1 phorylates and inhibits multiple nuclear proteins upon pharmaco- was suppressed, which promotes phosphorylation of several proteins logical mTORC1 suppression, such as TIP60, c-Myc, and FOXK1 such as GTF2F1 and FOXK1. Importantly, nuclear localization of GSK3 (6, 9, 10). Therefore, one prediction is that, upon rapamycin is sufficient to suppress cell proliferation. Additionally, expression of treatment, GSK3 inhibitory phosphorylation is lost, resulting in inhibition of proliferation. However, it has been reported that a nuclear exporter of GSK3, FRAT, restricts the nuclear localization CELL BIOLOGY GSK3 phosphorylation was not significantly suppressed by of GSK3, represses nuclear protein phosphorylation, and prevents rapamycin treatment in multiple cell lines (8). Additionally, we have rapamycin-induced cytostasis. Finally, we observe a correlation be- observed that GSK3-dependent regulation of FOXK1 phosphory- tween rapamycin resistance and FRAT expression in multiple-cancer lation occurred under conditions where GSK3 phosphorylation cell lines. Resistance to Food and Drug Administration (FDA)- was not significantly affected upon mTORC1 suppression, suggesting approved rapamycin analogs (rapalogs) is observed in many tumor a possible phosphorylation-independent mechanism for regu- settings, but the underling mechanisms remain incompletely under- lation of GSK3 by mTORC1 signaling (9). Thus, the relationship stood. Given that FRAT expression levels are frequently elevated in between mTORC1, GSK3, and rapamycin resistance remains various cancers, our observations provide a potential biomarker and unclear. strategy for overcoming rapamycin resistance. Here we report that the nuclear−cytoplasmic localization of GSK3 is regulated by mTORC1 signaling, which subsequently mTOR | GSK3 | FRAT | Resistance contributes to multiple nuclear protein phosphorylation events. The mTORC1 suppression leads to accumulation of GSK3 in the he protein kinase complex mechanistic target of rapamycin nucleus, thereby promoting the phosphorylation of GSK3 targets Tcomplex 1 (mTORC1) is a central regulator of mammalian cell growth and proliferation that is dysregulated in various Significance cancer types, including colorectal, breast, lung, renal cell carci- noma, glioblastoma, and prostate cancers (1). Several rapalogs The clinical effectiveness of FDA-approved anticancer rapalogs is (rapamycin and its derivatives) have been developed and Food limited because resistance is observed in multiple-tumor set- and Drug Administration (FDA)-approved for cancer treatment tings. In order to improve the efficacy of rapalogs, there is a (2). However, the impact of rapalogs in the clinic has been limited, need to improve our ability to predict and overcome rapamycin as resistance to rapalogs is frequently observed upon long-term resistance. Here we report that high FRAT1/2 expression confers treatment. In order to improve anticancer efficacy of rapalogs, rapamycin resistance by excluding GSK3 from the nucleus in there is a need to improve our understanding of these resistance multiple-cancer cell lines. FRAT1 expression is frequently high in mechanisms. As a central signaling cascade, once activated, mTORC1 multiple cancers, and our observations provide evidence for promotes multiple anabolic processes by phosphorylating a num- using FRAT1/2 expression as a biomarker for rapamycin sensi- ber of downstream substrates, including S6K1, 4EBPs, Grb10, tivity. Moreover, our findings reveal a major mechanism for how Lipin1, and others (1). Changes in mTORC1 signaling are also mTORC1 regulates nuclear protein phosphorylation and signal- understood to influence several biological processes that are ing, and uncover a potential therapeutic approach for targeting spatially restricted to the nucleus, including gene transcription, mTORC1-driven cancers. messenger RNA (mRNA) splicing, and chromosome remodel- ing. However, despite the significant advances made in un- Author contributions: L.H., B.Y.K., and J.B. designed research; L.H., D.L.F., and A.L. per- derstanding the mTORC1 pathway in the past 2 decades, how formed research; A.P.M. analyzed data; and L.H., M.J.N., and J.B. wrote the paper. mTORC1 signaling controls nuclear events is still not fully de- The authors declare no conflict of interest. fined, and whether nuclear signaling contributes to rapamycin This article is a PNAS Direct Submission. resistance observed during chronic treatment is unknown. Published under the PNAS license. GSK3 is known to phosphorylate a large number of substrates 1To whom correspondence may be addressed. Email: [email protected] or important in regulating cell growth and metabolism (3). Inap- [email protected]. propriate regulation of GSK3 is linked to several disorders, in- This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. cluding cancer (3, 4). In contrast to mTORC1, GSK3α/β have 1073/pnas.1902397116/-/DCSupplemental. relatively high activity in resting cells, which is suppressed upon www.pnas.org/cgi/doi/10.1073/pnas.1902397116 PNAS Latest Articles | 1of7 Downloaded by guest on October 1, 2021 such as FOXK1 and GTF2F1. Critically, we found the GSK3 Results interacting proteins, frequently rearranged in advanced T lymphomas Nuclear Enrichment of GSK3 Promotes Protein Phosphorylation upon 1 and 2 (FRAT1 and 2), which promote GSK3 nuclear export, pre- mTORC1 Suppression. The mTORC1 and downstream effectors vent rapamycin-induced nuclear accumulation of GSK3 and phos- such as ULK1/2, S6 protein kinases (S6K1/2), and SRPK2 reg- phorylation of its targets. Given these observations, we asked whether ulate the phosphorylation of a variety of proteins that affect mTORC1-GSK3 nuclear signaling was a major contributor to cell multiple cellular events associated with metabolism, mRNA proliferation and whether failure to promote GSK3 nuclear signaling processing and translation, survival signaling, autophagy, and cell might contribute to rapamycin resistance. In support of this possibility, growth (1, 11). An important observation made upon analysis of we observed that ectopic expression of GSK3 that is forced to locate the mTORC1 phosphoproteome revealed that, in addition to the in the nucleus (NLS-GSK3) promotes phosphorylation of proteins promotion of phosphorylation via mTORC1 signaling, the such as FOXK1 and GTF2F1, and, importantly, suppresses cancer phosphorylation of ∼100 proteins appeared to be suppressed by cell proliferation. We also observed that overexpression FRAT1/2 in mTORC1 (12). To investigate this unexpected role of mTORC1 rapamycin-sensitive cancer cells promotes resistance to the cytostatic in suppressing protein phosphorylation, we characterized phos- effects of rapamycin, consistent with the acquisition of drug resistance. phorylation of a transcription factor FOXK1, and demonstrated Consistently, cells with high FRAT1/2 expression are relatively in- that mTORC1 suppresses FOXK1 phosphorylation in a GSK3- sensitive to rapamycin treatment, and down-regulation of FRAT1/2 dependent manner (9). Furthermore, many of the phosphopro- with RNA interference (RNAi) resensitizes cells to rapamycin. Our teins identified in this analysis are also nuclear resident proteins SI Appendix observations in xenograft models further support the conclusion that with potential, conserved GSK3 sites ( , Table S1). To elevated expression of FRAT1/2, and suppression of GSK3 nuclear determine whether there are additional proteins whose phos- flux, are potential mechanisms by which cancer cells acquire rapa- phorylation is suppressed by mTORC1, we utilized available mycin resistance. Collectively, our findings demonstrate that moni- reagents to monitor the phosphorylation of another nuclear toring FRAT1/2 expression levels and/or GSK3 localization
Load more

Recommended publications
  • Posters A.Pdf
    INVESTIGATING THE COUPLING MECHANISM IN THE E. COLI MULTIDRUG TRANSPORTER, MdfA, BY FLUORESCENCE SPECTROSCOPY N. Fluman, D. Cohen-Karni, E. Bibi Department of Biological Chemistry, Weizmann Institute of Science, Rehovot, Israel In bacteria, multidrug transporters couple the energetically favored import of protons to export of chemically-dissimilar drugs (substrates) from the cell. By this function, they render bacteria resistant against multiple drugs. In this work, fluorescence spectroscopy of purified protein is used to unravel the mechanism of coupling between protons and substrates in MdfA, an E. coli multidrug transporter. Intrinsic fluorescence of MdfA revealed that binding of an MdfA substrate, tetraphenylphosphonium (TPP), induced a conformational change in this transporter. The measured affinity of MdfA-TPP was increased in basic pH, raising a possibility that TPP might bind tighter to the deprotonated state of MdfA. Similar increases in affinity of TPP also occurred (1) in the presence of the substrate chloramphenicol, or (2) when MdfA is covalently labeled by the fluorophore monobromobimane at a putative chloramphenicol interacting site. We favor a mechanism by which basic pH, chloramphenicol binding, or labeling with monobromobimane, all induce a conformational change in MdfA, which results in deprotonation of the transporter and increase in the affinity of TPP. PHENOTYPE CHARACTERIZATION OF AZOSPIRILLUM BRASILENSE Sp7 ABC TRANSPORTER (wzm) MUTANT A. Lerner1,2, S. Burdman1, Y. Okon1,2 1Department of Plant Pathology and Microbiology, Faculty of Agricultural, Food and Environmental Quality Sciences, Hebrew University of Jerusalem, Rehovot, Israel, 2The Otto Warburg Center for Agricultural Biotechnology, Faculty of Agricultural, Food and Environmental Quality Sciences, Hebrew University of Jerusalem, Rehovot, Israel Azospirillum, a free-living nitrogen fixer, belongs to the plant growth promoting rhizobacteria (PGPR), living in close association with plant roots.
    [Show full text]
  • Downloaded the “Top Edge” Version
    bioRxiv preprint doi: https://doi.org/10.1101/855338; this version posted December 6, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Drosophila models of pathogenic copy-number variant genes show global and 2 non-neuronal defects during development 3 Short title: Non-neuronal defects of fly homologs of CNV genes 4 Tanzeen Yusuff1,4, Matthew Jensen1,4, Sneha Yennawar1,4, Lucilla Pizzo1, Siddharth 5 Karthikeyan1, Dagny J. Gould1, Avik Sarker1, Yurika Matsui1,2, Janani Iyer1, Zhi-Chun Lai1,2, 6 and Santhosh Girirajan1,3* 7 8 1. Department of Biochemistry and Molecular Biology, Pennsylvania State University, 9 University Park, PA 16802 10 2. Department of Biology, Pennsylvania State University, University Park, PA 16802 11 3. Department of Anthropology, Pennsylvania State University, University Park, PA 16802 12 4 contributed equally to work 13 14 *Correspondence: 15 Santhosh Girirajan, MBBS, PhD 16 205A Life Sciences Building 17 Pennsylvania State University 18 University Park, PA 16802 19 E-mail: [email protected] 20 Phone: 814-865-0674 21 1 bioRxiv preprint doi: https://doi.org/10.1101/855338; this version posted December 6, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 22 ABSTRACT 23 While rare pathogenic copy-number variants (CNVs) are associated with both neuronal and non- 24 neuronal phenotypes, functional studies evaluating these regions have focused on the molecular 25 basis of neuronal defects.
    [Show full text]
  • Analysis of the Indacaterol-Regulated Transcriptome in Human Airway
    Supplemental material to this article can be found at: http://jpet.aspetjournals.org/content/suppl/2018/04/13/jpet.118.249292.DC1 1521-0103/366/1/220–236$35.00 https://doi.org/10.1124/jpet.118.249292 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS J Pharmacol Exp Ther 366:220–236, July 2018 Copyright ª 2018 by The American Society for Pharmacology and Experimental Therapeutics Analysis of the Indacaterol-Regulated Transcriptome in Human Airway Epithelial Cells Implicates Gene Expression Changes in the s Adverse and Therapeutic Effects of b2-Adrenoceptor Agonists Dong Yan, Omar Hamed, Taruna Joshi,1 Mahmoud M. Mostafa, Kyla C. Jamieson, Radhika Joshi, Robert Newton, and Mark A. Giembycz Departments of Physiology and Pharmacology (D.Y., O.H., T.J., K.C.J., R.J., M.A.G.) and Cell Biology and Anatomy (M.M.M., R.N.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada Received March 22, 2018; accepted April 11, 2018 Downloaded from ABSTRACT The contribution of gene expression changes to the adverse and activity, and positive regulation of neutrophil chemotaxis. The therapeutic effects of b2-adrenoceptor agonists in asthma was general enriched GO term extracellular space was also associ- investigated using human airway epithelial cells as a therapeu- ated with indacaterol-induced genes, and many of those, in- tically relevant target. Operational model-fitting established that cluding CRISPLD2, DMBT1, GAS1, and SOCS3, have putative jpet.aspetjournals.org the long-acting b2-adrenoceptor agonists (LABA) indacaterol, anti-inflammatory, antibacterial, and/or antiviral activity. Numer- salmeterol, formoterol, and picumeterol were full agonists on ous indacaterol-regulated genes were also induced or repressed BEAS-2B cells transfected with a cAMP-response element in BEAS-2B cells and human primary bronchial epithelial cells by reporter but differed in efficacy (indacaterol $ formoterol .
    [Show full text]
  • Exploring the Relationship Between Gut Microbiota and Major Depressive Disorders
    E3S Web of Conferences 271, 03055 (2021) https://doi.org/10.1051/e3sconf/202127103055 ICEPE 2021 Exploring the Relationship between Gut Microbiota and Major Depressive Disorders Catherine Tian1 1Shanghai American School, Shanghai, China Abstract. Major Depressive Disorder (MDD) is a psychiatric disorder accompanied with a high rate of suicide, morbidity and mortality. With the symptom of an increasing or decreasing appetite, there is a possibility that MDD may have certain connections with gut microbiota, the colonies of microbes which reside in the human digestive system. In recent years, more and more studies started to demonstrate the links between MDD and gut microbiota from animal disease models and human metabolism studies. However, this relationship is still largely understudied, but it is very innovative since functional dissection of this relationship would furnish a new train of thought for more effective treatment of MDD. In this study, by using multiple genetic analytic tools including Allen Brain Atlas, genetic function analytical tools, and MicrobiomeAnalyst, I explored the genes that shows both expression in the brain and the digestive system to affirm that there is a connection between gut microbiota and the MDD. My approach finally identified 7 MDD genes likely to be associated with gut microbiota, implicating 3 molecular pathways: (1) Wnt Signaling, (2) citric acid cycle in the aerobic respiration, and (3) extracellular exosome signaling. These findings may shed light on new directions to understand the mechanism of MDD, potentially facilitating the development of probiotics for better psychiatric disorder treatment. 1 Introduction 1.1 Major Depressive Disorder Major Depressive Disorder (MDD) is a mood disorder that will affect the mood, behavior and other physical parts.
    [Show full text]
  • The Database of Chromosome Imbalance Regions and Genes
    Lo et al. BMC Cancer 2012, 12:235 http://www.biomedcentral.com/1471-2407/12/235 RESEARCH ARTICLE Open Access The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization Fang-Yi Lo1, Jer-Wei Chang1, I-Shou Chang2, Yann-Jang Chen3, Han-Shui Hsu4, Shiu-Feng Kathy Huang5, Fang-Yu Tsai2, Shih Sheng Jiang2, Rajani Kanteti6, Suvobroto Nandi6, Ravi Salgia6 and Yi-Ching Wang1* Abstract Background: Cancer-related genes show racial differences. Therefore, identification and characterization of DNA copy number alteration regions in different racial groups helps to dissect the mechanism of tumorigenesis. Methods: Array-comparative genomic hybridization (array-CGH) was analyzed for DNA copy number profile in 40 Asian and 20 Caucasian lung cancer patients. Three methods including MetaCore analysis for disease and pathway correlations, concordance analysis between array-CGH database and the expression array database, and literature search for copy number variation genes were performed to select novel lung cancer candidate genes. Four candidate oncogenes were validated for DNA copy number and mRNA and protein expression by quantitative polymerase chain reaction (qPCR), chromogenic in situ hybridization (CISH), reverse transcriptase-qPCR (RT-qPCR), and immunohistochemistry (IHC) in more patients. Results: We identified 20 chromosomal imbalance regions harboring 459 genes for Caucasian and 17 regions containing 476 genes for Asian lung cancer patients. Seven common chromosomal imbalance regions harboring 117 genes, included gain on 3p13-14, 6p22.1, 9q21.13, 13q14.1, and 17p13.3; and loss on 3p22.2-22.3 and 13q13.3 were found both in Asian and Caucasian patients.
    [Show full text]
  • The Expression Profile of FRAT1 in Human Gliomas
    BRAIN RESEARCH 1320 (2010) 152– 158 available at www.sciencedirect.com www.elsevier.com/locate/brainres Research Report The expression profile of FRAT1 in human gliomas Geng Guoa,1, Xinggang Maoa,1, Peng Wanga,1, Bolin Liua, Xiang Zhanga,⁎, Xiaofan Jianga, Chengliang Zhongb, Junli Huoa, Ji Jinc, Yuzhen Zhuod aDepartment of Neurosurgery, Xijing Hospital, Fourth Military Medical University, 15# West Chang Le Road, Xi'an, Shaanxi Province 710032, People's Republic of China bDepartment of Health Statistics, Faculty of Preventative Medicine, Fourth Military Medical University, 17# West Chang Le Road, Xi'an, Shaanxi Province 710032, People's Republic of China cShanxi Medical University, 56# South Xin Jian Road, Taiyuan, Shanxi Province 030001, People's Republic of China dTianjin Institute of Acute Abdomen, Tianjin Nankai Hospital, 122# San Wei Road, Tianjin 300100, People's Republic of China ARTICLE INFO ABSTRACT Article history: FRAT1 was originally characterized as a protein frequently rearranged in advanced T cell Accepted 13 January 2010 lymphoma, which inhibits GSK-3-mediated phosphorylation of β-catenin and positively Available online 21 January 2010 regulates the Wnt signaling pathway. FRAT1 has been identified as a proto-oncogene involved in tumorigenesis. Previous studies have shown that FRAT1 is strikingly Keywords: overexpressed in some human cancers. However, the relationship between FRAT1 and FRAT1 human gliomas is unclear. In this study, we detected the expression of FRAT1 in human β-catenin gliomas by immunohistochemistry, Western blot and RT-PCR. FRAT1 was found to be Glioma specifically expressed in the majority of glioma samples, and their expression levels Immunohistochemistry increased markedly with the increase of WHO grades.
    [Show full text]
  • GSK-3) in Dictyostelium Discoideum and the Role of GSK-3 Binding Partners in Dictyostelium Discoideum and Mammalian Cells
    Investigation into the role of Glycogen Synthase Kinase 3 (GSK-3) in Dictyostelium discoideum and the role of GSK-3 binding partners in Dictyostelium discoideum and mammalian cells Josephine E. Forde School of Biosciences Cardiff University PhD Thesis Submitted: November 2009 UMI Number: U585B60 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. Dissertation Publishing UMI U585B60 Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author. Microform Edition © ProQuest LLC. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 Ca r d if f UNIVERSITY PRIFYSGOL DECLARATION C a e RD yi §> This work has not previously been accepted in substance for any degree and is not concurrently submitted in candidature for any degree. Signed ........... d & c k . - . ...................... (candidate) Date ... ! H | Q s | a o \ p .......... STATEMENT 1 This thesis is being submitted in partial fulfillment of the requirements for the degree of .................... (insert MCh, MD, MPhil, PhD etc, as appropriate) Signed .......d & 0 ( L : ...................... (candidate) Date ........... STATEMENT 2 This thesis is the result of my own independent work/investigation, except where otherwise stated. Other sources are acknowledged by explicit references. Signed d 6 < L - . ............................ (candidate) Date .
    [Show full text]
  • 1471-2105-8-217.Pdf
    BMC Bioinformatics BioMed Central Software Open Access GenMAPP 2: new features and resources for pathway analysis Nathan Salomonis1,2, Kristina Hanspers1, Alexander C Zambon1, Karen Vranizan1,3, Steven C Lawlor1, Kam D Dahlquist4, Scott W Doniger5, Josh Stuart6, Bruce R Conklin1,2,7,8 and Alexander R Pico*1 Address: 1Gladstone Institute of Cardiovascular Disease, 1650 Owens Street, San Francisco, CA 94158 USA, 2Pharmaceutical Sciences and Pharmacogenomics Graduate Program, University of California, 513 Parnassus Avenue, San Francisco, CA 94143, USA, 3Functional Genomics Laboratory, University of California, Berkeley, CA 94720 USA, 4Department of Biology, Loyola Marymount University, 1 LMU Drive, MS 8220, Los Angeles, CA 90045 USA, 5Computational Biology Graduate Program, Washington University School of Medicine, St. Louis, MO 63108 USA, 6Department of Biomolecular Engineering, University of California, Santa Cruz, CA 95064 USA, 7Department of Medicine, University of California, San Francisco, CA 94143 USA and 8Department of Molecular and Cellular Pharmacology, University of California, San Francisco, CA 94143 USA Email: Nathan Salomonis - [email protected]; Kristina Hanspers - [email protected]; Alexander C Zambon - [email protected]; Karen Vranizan - [email protected]; Steven C Lawlor - [email protected]; Kam D Dahlquist - [email protected]; Scott W Doniger - [email protected]; Josh Stuart - [email protected]; Bruce R Conklin - [email protected]; Alexander R Pico* - [email protected] * Corresponding author Published: 24 June 2007 Received: 16 November 2006 Accepted: 24 June 2007 BMC Bioinformatics 2007, 8:217 doi:10.1186/1471-2105-8-217 This article is available from: http://www.biomedcentral.com/1471-2105/8/217 © 2007 Salomonis et al; licensee BioMed Central Ltd.
    [Show full text]
  • Rewirable Gene Regulatory Networks in the Preimplantation Embryonic Development of Three Mammalian Species
    Downloaded from genome.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press Research Rewirable gene regulatory networks in the preimplantation embryonic development of three mammalian species Dan Xie,1,9 Chieh-Chun Chen,1,9 Leon M. Ptaszek,2,3,4,9 Shu Xiao,1 Xiaoyi Cao,5 Fang Fang,6 Huck H. Ng,6 Harris A. Lewin,7 Chad Cowan,3,4 and Sheng Zhong1,7,8,10 1Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA; 2Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA; 3Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts 02138, USA; 4Cardiovascular Research Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA; 5Center for Biophysics and Computational Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA; 6Gene Regulation Laboratory, Genome Institute of Singapore, 138672 Singapore, Singapore; 7Institute for Genomic Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA; 8Department of Statistics, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801, USA Mammalian preimplantation embryonic development (PED) is thought to be governed by highly conserved processes. While it had been suggested that some plasticity of conserved signaling networks exists among different mammalian species, it was not known to what extent modulation of the genomes and the regulatory proteins could ‘‘rewire’’ the gene regulatory networks (GRN) that control PED. We therefore generated global transcriptional profiles from three mam- malian species (human, mouse, and bovine) at representative stages of PED, including: zygote, two-cell, four-cell, eight-cell, 16-cell, morula and blastocyst.
    [Show full text]
  • Peptidomic Discovery of Short Open Reading Frame-Encoded Peptides in Human Cells
    Peptidomic discovery of short open reading frame-encoded peptides in human cells The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Slavoff, Sarah A., Andrew J. Mitchell, Adam G. Schwaid, Moran N. Cabili, Jiao Ma, Joshua Z. Levin, Amir D. Karger, Bogdan A. Budnik, John L. Rinn, and Alan Saghatelian. 2013. “Peptidomic discovery of short open reading frame-encoded peptides in human cells.” Nature chemical biology 9 (1): 59-64. doi:10.1038/nchembio.1120. http:// dx.doi.org/10.1038/nchembio.1120. Published Version doi:10.1038/nchembio.1120 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11717493 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA NIH Public Access Author Manuscript Nat Chem Biol. Author manuscript; available in PMC 2013 July 01. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Nat Chem Biol. 2013 January ; 9(1): 59–64. doi:10.1038/nchembio.1120. Peptidomic discovery of short open reading frame-encoded peptides in human cells Sarah A. Slavoff1, Andrew J. Mitchell2,*, Adam G. Schwaid1,*, Moran N. Cabili3,4,5, Jiao Ma1, Joshua Z. Levin6, Amir D. Karger7, Bogdan A. Budnik8, John L. Rinn3,5, and Alan Saghatelian1,† 1Department of Chemistry and Chemical Biology, Harvard University,
    [Show full text]
  • Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and B-Catenin– Independent Targets by Proteomics
    Published OnlineFirst June 3, 2019; DOI: 10.1158/1541-7786.MCR-18-1154 Cancer "-omics" Molecular Cancer Research Identification of Endogenous Adenomatous Polyposis Coli Interaction Partners and b-Catenin– Independent Targets by Proteomics Olesja Popow1,2,3,Joao~ A. Paulo2, Michael H. Tatham4, Melanie S. Volk3, Alejandro Rojas-Fernandez5, Nicolas Loyer3, Ian P. Newton3, Jens Januschke3, Kevin M. Haigis1,6, and Inke Nathke€ 3 Abstract Adenomatous Polyposis Coli (APC) is the most frequently tion between endogenous MINK1 and APC and further mutated gene in colorectal cancer. APC negatively regulates confirmed the negative, and b-catenin–independent, regu- the Wnt signaling pathway by promoting the degradation of lation of MINK1 by APC. Increased Mink1/Msn levels were b-catenin, but the extent to which APC exerts Wnt/b-cate- also observed in mouse intestinal tissue and Drosophila nin–independent tumor-suppressive activity is unclear. To follicular cells expressing mutant Apc/APC when compared identify interaction partners and b-catenin–independent with wild-type tissue/cells. Collectively, our results highlight targets of endogenous, full-length APC, we applied label- the extent and importance of Wnt-independent APC func- free and multiplexed tandem mass tag-based mass spec- tions in epithelial biology and disease. trometry. Affinity enrichment-mass spectrometry identified more than 150 previously unidentified APC interaction Implications: The tumor-suppressive function of APC, the partners. Moreover, our global proteomic analysis revealed most frequently mutated gene in colorectal cancer, is mainly that roughly half of the protein expression changes that attributed to its role in b-catenin/Wnt signaling. Our study occur in response to APC loss are independent of b-catenin.
    [Show full text]
  • Insulin-Like Growth Factor 1 Is a Direct HOXA9 Target Important for Hematopoietic Transformation
    Leukemia (2015) 29, 901–908 © 2015 Macmillan Publishers Limited All rights reserved 0887-6924/15 www.nature.com/leu ORIGINAL ARTICLE Insulin-like growth factor 1 is a direct HOXA9 target important for hematopoietic transformation J Steger, E Füller, M-P Garcia-Cuellar, K Hetzner and RK Slany HOX homeobox proteins are key oncogenic drivers in hematopoietic malignancies. Here we demonstrate that HOXA1, HOXA6 and predominantly HOXA9 are able to induce the production of insulin-like growth factor 1 (Igf1). In chromatin immunoprecipitations, HOXA9 bound directly to the putative promoter and a DNase-hypersensitive region in the first intron of the Igf1 gene. Transcription rates of the Igf1 gene paralleled HOXA9 activity. Primary cells transformed by HOXA9 expressed functional Igf1 receptors and activated the protein kinase Akt in response to Igf1 stimulation, suggesting the existence of an autocrine signaling loop. Genomic deletion of the Igf1 gene by Cre-mediated recombination increased sensitivity toward apoptosis after serum starvation. In addition, the leukemogenic potential of Igf1-negative, HOXA9-transformed cells was impaired, leading to a significant delay in disease development on transplantation into recipient animals. Leukemia (2015) 29, 901–908; doi:10.1038/leu.2014.287 INTRODUCTION factor FGF2 (fibroblast growth factor) are regulated by HOX 14,15 HOX homeobox genes are increasingly acknowledged as impor- proteins. Apart from these examples and despite the tant drivers of malignant transformation in the hematopoietic discovery of numerous HOXA9-binding sites across the genome 16 system. In line with their major regulatory role in hematopoietic by chromatin immunoprecipitation-sequencing ChIP-Seq, func- stem and precursor cell populations, HOX transcription needs to tionally characterized HOX targets are scarce.
    [Show full text]